Amie J Goodin

Amie J Goodin, Ph.D.

Assistant Professor

Department: Pharmaceutical Outcomes & Policy
Business Phone: (352) 294-8829
Business Email: amie.goodin@cop.ufl.edu

About Amie J Goodin

Dr. Goodin is an Assistant Professor within the Department of Pharmaceutical Outcomes and Policy (POP) and the Center for Drug Evaluation and Safety (CoDES). She received her Master of Public Policy degree from the University of Kentucky (UK). She completed her Doctor of Philosophy degree at UK’s Martin School of Public Policy, with specialization in pharmaceutical outcomes and an additional Certificate in Informatics. She completed a Postdoctoral Fellowship at University of Florida POP, specializing in pharmacoepidemiology methods while continuing her work in Health Services Research. She is the lead for Health Services Research track within POP’s graduate program as well as the faculty lead for Research Strategy within the Consortium for Medical Marijuana Clinical Outcomes Research. Currently, her research projects incorporate mixed-method approaches to assess the impact of policy changes related to treatment access and utilization for Substance Use Disorders, particularly among persons enrolled in Medicaid and pregnant women.

Research Profile

Open Researcher and Contributor ID (ORCID)

0000-0002-0020-8720

Areas of Interest
  • Health Policy
  • Health disparities and vulnerable populations
  • Maternal and Child Health
  • Substance Use Disorders
  • health services research

Publications

2021
A Pharmacoepidemiologic Approach to Evaluate Real-world Effectiveness of Hormonal Contraceptives in the Presence of Drug-drug Interactions.
Epidemiology (Cambridge, Mass.). 32(2):268-276 [DOI] 10.1097/EDE.0000000000001302. [PMID] 33196560.
2021
A survey assessment of clinician perceptions of opioid supply and monitoring requirement policy changes.
Journal of opioid management. 17(4):337-342 [DOI] 10.5055/jom.2021.0666. [PMID] 34533828.
2021
Cannabis use assessment and documentation in healthcare: Priorities for closing the gap.
Preventive medicine. [DOI] 10.1016/j.ypmed.2021.106798. [PMID] 34506820.
2021
Changes in Prescribing by Provider Type Following a State Prescription Opioid Restriction Law.
Journal of general internal medicine. [DOI] 10.1007/s11606-021-06966-4. [PMID] 34236602.
2021
Changes in Quantity of Opioids Dispensed following Florida’s Restriction Law for Acute Pain Prescriptions.
Pain medicine (Malden, Mass.). 22(8):1870-1876 [DOI] 10.1093/pm/pnab017. [PMID] 33502536.
2021
Changes in Schedule II oral opioid volume dispensed in a private health plan following Florida’s Acute Pain Opioid Restriction Law.
Journal of managed care & specialty pharmacy. 27(6):779-784 [DOI] 10.18553/jmcp.2021.27.6.779. [PMID] 34057389.
2021
Chronic Opioid Therapy: A Scoping Literature Review on Evolving Clinical and Scientific Definitions.
The journal of pain. 22(3):246-262 [DOI] 10.1016/j.jpain.2020.09.002. [PMID] 33031943.
2021
Effects of hydrocodone rescheduling on opioid use outcomes: A systematic review.
Journal of the American Pharmacists Association : JAPhA. 61(2):e20-e44 [DOI] 10.1016/j.japh.2020.09.013. [PMID] 33127312.
2021
Natural and Synthetic Cannabinoids: Pharmacology, Uses, Adverse Drug Events, and Drug Interactions.
Journal of clinical pharmacology. 61 Suppl 2:S37-S52 [DOI] 10.1002/jcph.1871. [PMID] 34396558.
2021
Obstetrician-gynecologist perceptions and utilization of prescription drug monitoring programs: A survey study.
Medicine. 100(1) [DOI] 10.1097/MD.0000000000024268. [PMID] 33429837.
2021
Outpatient Off-Label Gabapentin Use for Psychiatric Indications Among U.S. Adults, 2011-2016.
Psychiatric services (Washington, D.C.). [DOI] 10.1176/appi.ps.202000338. [PMID] 34015964.
2021
Trends in Use of Prescription Nonsteroidal Anti-inflammatory Medications Before vs After Implementation of a Florida Law Restricting Opioid Prescribing for Acute Pain.
JAMA network open. 4(6) [DOI] 10.1001/jamanetworkopen.2021.13383. [PMID] 34115125.
2020
Appalachian disparities in tobacco cessation treatment utilization in Medicaid.
Substance abuse treatment, prevention, and policy. 15(1) [DOI] 10.1186/s13011-020-0251-0. [PMID] 31959212.
2020
Assessing the utility of the Healthy Start Screen to predict an elevated Edinburgh Postnatal Depression Scale score.
Journal of perinatal medicine. 48(5):483-487 [DOI] 10.1515/jpm-2019-0472. [PMID] 32286250.
2020
Changes in Opioid Use After Florida’s Restriction Law for Acute Pain Prescriptions.
JAMA network open. 3(2) [DOI] 10.1001/jamanetworkopen.2020.0234. [PMID] 32108887.
2020
Characteristics of Older Adults Who Were Early Adopters of Medical Cannabis in the Florida Medical Marijuana Use Registry.
Journal of clinical medicine. 9(4) [DOI] 10.3390/jcm9041166. [PMID] 32325769.
2020
Domperidone prescribing patterns in pediatric patients before and after safety warning in South Korea.
International journal of clinical pharmacology and therapeutics. 58(12):687-695 [DOI] 10.5414/CP203688. [PMID] 32831161.
2020
Healthcare Utilization and Physical Functioning in Older Adults in the United States.
Journal of the American Geriatrics Society. 68(2):266-271 [DOI] 10.1111/jgs.16260.
2020
Impact of an on-site perinatal mood disorders clinic in the diagnosis and management of perinatal mood disorders.
Journal of perinatal medicine. 48(8):837-843 [DOI] 10.1515/jpm-2020-0036. [PMID] 32764166.
2020
Increased Tdap and Influenza Vaccination Acquisition Among Patients Participating in Group Prenatal Care.
The journal of primary prevention. 41(5):413-420 [DOI] 10.1007/s10935-020-00606-z. [PMID] 32889665.
2020
OB/GYN perceptions of prescription drug monitoring programs as a primary prevention tool for neonatal abstinence syndrome.
Research in social & administrative pharmacy : RSAP. 16(12):1789-1791 [DOI] 10.1016/j.sapharm.2020.03.010. [PMID] 32265114.
2020
Perception of prescription drug monitoring programs as a prevention tool in primary medical care.
Research in social & administrative pharmacy : RSAP. 16(9):1306-1308 [DOI] 10.1016/j.sapharm.2019.03.012. [PMID] 30935769.
2020
Prevalence of substance use disorder and psychiatric comorbidity burden among pregnant women with opioid use disorder in a large administrative database, 2009-2014.
Journal of psychosomatic obstetrics and gynaecology. 1-7 [DOI] 10.1080/0167482X.2020.1727882. [PMID] 32067526.
2020
Prevalence of substance use disorder and psychiatric comorbidity burden among pregnant women with opioid use disorder in a large administrative database, 2009–2014
Journal of Psychosomatic Obstetrics & Gynecology. 1-7 [DOI] 10.1080/0167482x.2020.1727882.
2019
Mental health disparities and high-risk alcohol use among non-heterosexual high school students.
Perspectives in psychiatric care. 55(4):570-575 [DOI] 10.1111/ppc.12394. [PMID] 31066062.
2019
Perinatal Navigator Approach to Smoking Cessation for Women With Prevalent Opioid Dependence.
Western journal of nursing research. 41(8):1103-1120 [DOI] 10.1177/0193945918825381. [PMID] 30724661.
2019
Prevalence of Maternal-Risk Factors Related to Neonatal Abstinence Syndrome in a Commercial Claims Database: 2011-2015.
Pharmacotherapy. 39(10):1005-1011 [DOI] 10.1002/phar.2315. [PMID] 31361913.
2019
Substance Use and School Characteristics in Lesbian, Gay, Bisexual, and Heterosexual High School Students.
The Journal of school health. 89(3):219-225 [DOI] 10.1111/josh.12731. [PMID] 30637738.
2019
The prevalence of drivers under the influence of medical cannabis must be considered within proper context.
Research in social & administrative pharmacy : RSAP. 15(11):1372-1373 [DOI] 10.1016/j.sapharm.2019.01.015. [PMID] 30709730.
2018
A Review of Interventions to Increase Vena Cava Filter Retrieval Rates.
Annals of vascular surgery. 51:284-297 [DOI] 10.1016/j.avsg.2018.02.010. [PMID] 29655810.
2018
Hospitalization metrics associated with hospital-level variation in inferior vena cava filter utilization for patients with venous thromboembolism in the United States: Implications for quality of care.
Vascular medicine (London, England). 23(4):365-371 [DOI] 10.1177/1358863X18768685. [PMID] 29781388.
2018
Mass Casualty Shooting Venues, Types of Firearms, and Age of Perpetrators in the United States, 1982-2018.
American journal of public health. 108(10):1385-1387 [DOI] 10.2105/AJPH.2018.304584. [PMID] 30138068.
2018
Patient and hospital characteristics predictive of inferior vena cava filter usage in venous thromboembolism patients: A study from the 2013 to 2014 Nationwide Readmissions Database.
Medicine. 97(12) [DOI] 10.1097/MD.0000000000010149. [PMID] 29561421.
2018
Pharmacists’ role in harm reduction: a survey assessment of Kentucky community pharmacists’ willingness to participate in syringe/needle exchange.
Harm reduction journal. 15(1) [DOI] 10.1186/s12954-018-0211-4. [PMID] 29370808.
2018
Rapid Expansion of the Opioid Ecosystem: National Implications for Prescriber-Pharmacist Communication.
American journal of preventive medicine. 55(5):656-661 [DOI] 10.1016/j.amepre.2018.05.003. [PMID] 30219211.
2018
Risk Stratification for Bleeding Complications in Patients With Venous Thromboembolism: Application of the HAS-BLED Bleeding Score During the First 6 Months of Anticoagulant Treatment.
Journal of the American Heart Association. 7(6) [DOI] 10.1161/JAHA.117.007901. [PMID] 29514808.
2018
Rural and Appalachian Disparities in Neonatal Abstinence Syndrome Incidence and Access to Opioid Abuse Treatment.
The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association. 34(1):6-13 [DOI] 10.1111/jrh.12251. [PMID] 28685864.
2018
The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism: comment.
Journal of thrombosis and haemostasis : JTH. 16(12):2537-2539 [DOI] 10.1111/jth.14301. [PMID] 30240546.
2018
We Cannot Treat the Dead.
American journal of public health. 108(10):1286-1288 [DOI] 10.2105/AJPH.2018.304658. [PMID] 30207778.
2017
An investigation of factors predicting the type of bladder antimuscarinics initiated in Medicare nursing homes residents.
BMC geriatrics. 17(1) [DOI] 10.1186/s12877-017-0690-2. [PMID] 29282013.
2017
Pharmacists’ role in opioid overdose: Kentucky pharmacists’ willingness to participate in naloxone dispensing.
Journal of the American Pharmacists Association : JAPhA. 57(2S):S28-S33 [DOI] 10.1016/j.japh.2016.12.064. [PMID] 28139459.
2017
The Power and Pitfalls of Big Data Research in Obstetrics and Gynecology: A Consumer’s Guide.
Obstetrical & gynecological survey. 72(11):669-682 [DOI] 10.1097/OGX.0000000000000504. [PMID] 29164265.
2016
Smoking Cessation Awareness and Utilization Among Lesbian, Gay, Bisexual, and Transgender Adults: An Analysis of the 2009-2010 National Adult Tobacco Survey.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco. 18(4):496-500 [DOI] 10.1093/ntr/ntv103. [PMID] 26014455.
2015
Menthol cigarette smoking among lesbian, gay, bisexual, and transgender adults.
American journal of preventive medicine. 48(1):93-7 [DOI] 10.1016/j.amepre.2014.07.044. [PMID] 25245795.
2015
Online medical care: the current state of “eVisits” in acute primary care delivery.
Telemedicine journal and e-health : the official journal of the American Telemedicine Association. 21(2):90-6 [DOI] 10.1089/tmj.2014.0022. [PMID] 25474083.
2015
Prescription drug monitoring program utilization in Kentucky community pharmacies.
Pharmacy practice. 13(2) [PMID] 26131042.
View on: PubMed
2015
Smoking characteristics among lesbian, gay, and bisexual adults.
Preventive medicine. 74:123-30 [DOI] 10.1016/j.ypmed.2014.11.026. [PMID] 25485860.
2014
Kentucky pharmacists’ opinions of the potential reclassification of pseudoephedrine as a legend drug.
Journal of the American Pharmacists Association : JAPhA. 54(4):397-405 [DOI] 10.1331/JAPhA.2014.13177. [PMID] 25063261.
2014
Smoke-free policy implementation: theoretical and practical considerations.
Policy, politics & nursing practice. 15(3-4):81-92 [DOI] 10.1177/1527154414562301. [PMID] 25573743.
2012
Consumer/patient encounters with prescription drug monitoring programs: evidence from a Medicaid population.
Pain physician. 15(3 Suppl):ES169-75 [PMID] 22786455.
View on: PubMed

Grants

Jul 2021 ACTIVE
Reducing Maternal Morbidity and Mortality in the Covid-19 Era and Beyond
Role: Co-Investigator
Funding: FL DEPT OF HLTH
Jan 2021 ACTIVE
Program Evaluation and Analytic Support Services for a Substance Use Disorders Recovery Community Center
Role: Principal Investigator
Funding: VOICES OF HOPE
Jan 2020 – Feb 2021
Leveraging social media data for evaluation of drug use trends after opioid policies
Role: Co-Investigator
Funding: AMER ASSO OF COL OF PHARMACY
Aug 2019 – Dec 2020
Program Evaluation and Analytic Support Services for a Substance Use Disorders Recovery Community Center
Role: Principal Investigator
Funding: VOICES OF HOPE
Apr 2019 – Apr 2020
Evaluating Learning Outcomes in Continuing Pharmacy and Medical Education
Role: Principal Investigator
Funding: CREATIVE EDUCATIONAL CONCEPTS
Mar 2017 – Jun 2020
All-cause readmission measures on inpatient psychiatry facilities
Role: Principal Investigator
Funding: UF HEALTH SHANDS HOSPITAL

Education

Ph.D.
2015 · University of Kentucky
M.P.P.
2009 · University of Kentucky
B.S.
2007 · University of Kentucky

Teaching Profile

Courses Taught
2020-2021
PHA5226C Pt Safety and Quality
2020-2021
PHA7979 Advanced Research
2020-2021
PHA6910 Supervised Research
2020-2021
PHA7980 Research for Doctoral Dissertation
2019-2021
PHA5007 Pharm and Pop Health
2020-2021
PHA6971 Research for Master’s Thesis
2020-2021
PHA6717 Measurement in Pharmacy Administration Research
2019,2021
PHA5789C Patient Care 7
2021
PHA6940 Supervised Teaching
2021
PHA6265 Introduction to Pharmaceutical Outcomes and Policy I
2021
PHA6937 Topics in Pharmaceutical Administration
2021
PHA6936 Advanced Topics in Pharmaceutical Sciences
2021
PHA6894 Introduction to Graduate Studies

Contact Details

Phones:
Business:
(352) 294-8829
Emails:

Recent news

New Florida law leads to decline in opioid use, according to UF study

UF researchers found the number of new opioid users per month dropped 16 percent immediately after Florida House Bill 21 was implemented.

UF Health researchers develop CMS quality measure to evaluate inpatient psychiatric hospitals

The UF measure tracks 30-day hospital readmission rates for psychiatric patients following discharge.

Dr. Amie Goodin featured in NY Times story on the opioid crisis

“Current policies to limit opioid prescriptions leave some pain patients high and dry, resulting in a new wave of unintended consequences for patients with untreated chronic pain.”

We Cannot Treat the Dead

Assistant Scientist Amie Goodin, Ph.D., publishes an editorial in the American Journal of Public Health on the opioid epidemic.